2023年修订的IgG4相关眼睛疾病的诊断标准
Masayuki Takahira1, Hiroshi Goto2, Atsushi Azumi3
1Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. takahira@med.kanazawa-u.ac.jp.
Japanese journal of ophthalmology
|July 22, 2024
概括
免疫球蛋白G4 (IgG4) 相关的眼睛疾病 (IgG4-ROD) 的修订诊断标准现在包括视神经病变,一种严重的眼部表现. 更新还扩大了淋巴瘤的差异诊断范围,超出了MALT淋巴瘤.
科学领域:
- 眼科医生 眼科 眼科
- 类风湿病学 类风湿病学
- 病理学 病理学 病理学
背景情况:
- 免疫球蛋白G4 (IgG4) 相关疾病 (IgG4-RD) 是一种全身性纤维炎症疾病.
- 与IgG4相关的眼部疾病 (IgG4-ROD) 涉及眼部附组织,但2014年的诊断标准省略了视神经病变.
- 视神经病是IgG4-RD的严重的眼科表现.
研究的目的:
- 建议对IgG4-ROD.的2023年诊断标准进行修订.
- 强调将视神经病变纳入IgG4-ROD诊断中.
- 改进差异诊断,特别是关于轨道淋巴瘤的差异诊断.
主要方法:
- 对IgG4相关疾病中视神经病变的已发表病例报告 (n=44) 的综述.
- 对治疗结果的分析,包括皮质类固醇,rituximab和手术.
- 拟议的2023年标准与现有的2014年标准的比较.
主要成果:
- 视神经病变是IgG4-RD的一个显著的眼科表现.
- 与IgG4相关的视神经病变的及时治疗可以导致视觉恢复.
- 在治疗前严重的视力丧失 (光感知或更少) 与较差的结果相关.
- 2014年的标准可能过度强调了粘膜相关淋巴组织 (MALT) 淋巴瘤.
结论:
- 对IgG4-ROD的2023年修订的诊断标准应该包括视神经病变.
- 早期诊断和治疗IgG4-ROD视神经病变对于维护视力至关重要.
- 对IgG4-ROD的差异诊断应该包括更广泛的轨道淋巴瘤,而不仅仅是MALT淋巴瘤.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...